Literature DB >> 33077907

A new potential risk factor for central serous chorioretinopathy: blood pressure variability.

Mehmet Fatih Karadağ1.   

Abstract

BACKGROUND/
OBJECTIVES: The choroid, mostly composed of vascular structures, can be directly affected by systemic hemodynamic changes. Blood pressure variability (BPV) may factor into choroidal dysfunction, which can be associated with the pathogenesis of central serous chorioretinopathy (CSCR). The aim of our study was to investigate short-term BPV over 24 h in patients with acute CSCR versus healthy controls. SUBJECTS/
METHODS: Our cross-sectional comparative study included 50 patients with CSCR (i.e., patient group) and 60 healthy individuals (i.e., control group). In all participants, 24-h ambulatory blood pressure was monitored every 15 min during the day and every 30 min at night. Mean variability index (VI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) during the day, at night, and across the 24-h period were subjected to statistical analyses.
RESULTS: Mean 24-h, daytime, and night-time SBP and DBP did not significantly differ between the groups. The mean 24-h and daytime VI values for SBP and DBP were significantly higher in the patient group than in the control group, whereas the mean night-time VI values for SBP and DBP between the groups were similar. Multivariate logistic regression models revealed that the VI values for 24-h and daytime SBP and DBP emerged as independent risk factors for developing CSCR.
CONCLUSION: Our study revealed that variabilities in 24-h, daytime SBP and DBP were significantly higher in patients with CSCR than in controls. Our results thus suggest that increased BPV may be a new risk factor for the development of CSCR.
© 2020. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2020        PMID: 33077907      PMCID: PMC8302670          DOI: 10.1038/s41433-020-01222-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  34 in total

1.  Central serous chorioretinopathy: a personal perspective.

Authors:  Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

2.  Feasibility and clinical utility of ultra-widefield indocyanine green angiography.

Authors:  Michael A Klufas; Nicolas A Yannuzzi; Claudine E Pang; Sowmya Srinivas; Srinivas R Sadda; K Bailey Freund; Szilárd Kiss
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

3.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Roberta Rigault de la Longrais; Giambattista Ravera; Chiara M Eandi; Luca Ventre; Ali' Abdollahi; Marilisa Manea
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

4.  Indocyanine green videoangiography of older patients with central serous chorioretinopathy.

Authors:  R F Spaide; L Hall; A Haas; L Campeas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Retina       Date:  1996       Impact factor: 4.256

Review 5.  Central serous chorioretinopathy.

Authors:  Raffael Liegl; Michael W Ulbig
Journal:  Ophthalmologica       Date:  2014-04-26       Impact factor: 3.250

6.  Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy.

Authors:  L A Yannuzzi; J L Shakin; Y L Fisher; M A Altomonte
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

7.  Indocyanine green angiographic findings in central serous chorioretinopathy.

Authors:  F C Piccolino; L Borgia; E Zinicola; M Zingirian
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

8.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

9.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

10.  Long-term follow-up of central serous retinopathy in 150 patients.

Authors:  J Castro-Correia; M F Coutinho; V Rosas; J Maia
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.